Pharmacokinetics of human alpha-atrial natriuretic peptide (alpha-hANP) in cow and dog. 1990

N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
Nippon Veterinary and Zootechnical College, Tokyo, Japan.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
February 1990, Chemical & pharmaceutical bulletin,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
March 1995, Nihon rinsho. Japanese journal of clinical medicine,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
August 1991, Chemical & pharmaceutical bulletin,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
August 2001, Canadian journal of physiology and pharmacology,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
November 1990, Biochemical and biophysical research communications,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
March 1985, Life sciences,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
March 1985, European journal of pharmacology,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
January 1985, Clinical and experimental hypertension. Part A, Theory and practice,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
August 1986, Acta physiologica Scandinavica,
N Takemura, and H Koyama, and T Sako, and K Ando, and K Suzuki, and S Motoyoshi, and F Marumo
June 2001, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!